Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
What is your approach to managing ESKD patients who are disruptive and threatening in the dialysis unit?
Related Questions
What is your approach to dosing sodium thiosulfate for a patient with ESKD who is receiving CRRT?
Is there a role for calcitriol in dialysis patients regardless of PTH level?
How would you counsel a patient with CKD Stage 5 and prediabetes who is concerned about their risk of developing diabetes if they start peritoneal dialysis?
Would you use IV albumin before hemodialysis for hypotension if the serum albumin is greater than 3.5 g/dl?
Would you continue spironolactone in a patient who has recently progressed to ESKD on HD with oliguria and was diagnosed with primary hyperaldosteronism years ago?
How do you determine when it is appropriate to transition a patient back to peritoneal dialysis after they were switched to hemodialysis due to PD catheter removal for refractory peritonitis, once the infection has been treated?
Would you consider treating hypercalcemia with CRRT and regional citrate anticoagulation for a dialysis dependent patient who does not respond to bisphosphonate therapy and low calcium dialysate bath?
What medications do you use to treat encapsulating peritoneal sclerosis?
Do you recommend avoiding ESAs in ESKD patients with heart failure who require a left ventricular assist device?
Is there a role for vadadustat in addition to an ESA in ESKD patients who are hyporesponsive to ESA’s alone?
